{
  "trial_id": "NCT01092182",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, HIV status, ECOG performance status, disease stage, renal function (serum creatinine, creatinine clearance), hepatic function (bilirubin levels), hematological function (absolute neutrophil count, platelet count), prior treatment history, presence of other medical conditions (ischemic heart disease, myocardial infarction, congestive heart failure), pregnancy status, contraception use, history of prior invasive malignancy, and immune suppression status in HIV-positive patients.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG)",
          "ECOG performance status"
        ],
        [
          "Histology",
          "prior treatment history"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Race/Ethnicity",
        "Region of Enrollment",
        "Baseline Risk Stratification",
        "International Prognostic Index Score 0-5"
      ],
      "remaining_candidate_features": [
        "HIV status",
        "disease stage",
        "renal function (serum creatinine, creatinine clearance)",
        "hepatic function (bilirubin levels)",
        "hematological function (absolute neutrophil count, platelet count)",
        "presence of other medical conditions (ischemic heart disease, myocardial infarction, congestive heart failure)",
        "pregnancy status",
        "contraception use",
        "history of prior invasive malignancy",
        "immune suppression status in HIV-positive patients."
      ]
    },
    "processed-gen-response": "Age, gender, HIV status, ECOG performance status, disease stage, renal function (serum creatinine, creatinine clearance), hepatic function (bilirubin levels), hematological function (absolute neutrophil count, platelet count), prior treatment history, presence of other medical conditions (ischemic heart disease, myocardial infarction, congestive heart failure), pregnancy status, contraception use, history of prior invasive malignancy, and immune suppression status in HIV-positive patients."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, HIV status, ECOG performance status, Serum creatinine, Creatinine clearance, Bilirubin, Absolute neutrophil count, Platelet count, Left ventricular ejection fraction,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG)",
          "ECOG performance status"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Region of Enrollment",
        "Baseline Risk Stratification",
        "International Prognostic Index Score 0-5",
        "Histology"
      ],
      "remaining_candidate_features": [
        "Region of Enrollment",
        "HIV status",
        "Serum creatinine",
        "Creatinine clearance",
        "Bilirubin",
        "Absolute neutrophil count",
        "Platelet count",
        "Left ventricular ejection fraction"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, HIV status, ECOG performance status, Serum creatinine, Creatinine clearance, Bilirubin, Absolute neutrophil count, Platelet count, Left ventricular ejection fraction"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, HIV Status, ECOG Performance Status, Histologic Diagnosis, Disease Stage, Prior Treatment, Hepatitis B Status, Creatinine Clearance, Bilirubin, Absolute Neutrophil Count, Platelet Count.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG)",
          "ECOG Performance Status"
        ],
        [
          "Histology",
          "Histologic Diagnosis"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Baseline Risk Stratification",
        "International Prognostic Index Score 0-5"
      ],
      "remaining_candidate_features": [
        "HIV Status",
        "Disease Stage",
        "Prior Treatment",
        "Hepatitis B Status",
        "Creatinine Clearance",
        "Bilirubin",
        "Absolute Neutrophil Count",
        "Platelet Count"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, HIV Status, ECOG Performance Status, Histologic Diagnosis, Disease Stage, Prior Treatment, Hepatitis B Status, Creatinine Clearance, Bilirubin, Absolute Neutrophil Count, Platelet Count."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "age, sex, race, ethnicity, body mass index (BMI), Eastern Cooperative Oncology Group (ECOG) performance status, HIV status, hepatitis B status, disease stage, histologic diagnosis, presence of c-MYC, presence of Burkitt lymphoma, presence of diffuse large B-cell lymphoma, presence of plasmablastic lymphoma.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Eastern Cooperative Oncology Group (ECOG)",
          "Eastern Cooperative Oncology Group (ECOG) performance status"
        ],
        [
          "Histology",
          "histologic diagnosis"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Region of Enrollment",
        "Baseline Risk Stratification",
        "International Prognostic Index Score 0-5"
      ],
      "remaining_candidate_features": [
        "ethnicity",
        "body mass index (BMI)",
        "HIV status",
        "hepatitis B status",
        "disease stage",
        "presence of c-MYC",
        "presence of Burkitt lymphoma",
        "presence of diffuse large B-cell lymphoma",
        "presence of plasmablastic lymphoma."
      ]
    },
    "processed-gen-response": "age, sex, race, ethnicity, body mass index (BMI), Eastern Cooperative Oncology Group (ECOG) performance status, HIV status, hepatitis B status, disease stage, histologic diagnosis, presence of c-MYC, presence of Burkitt lymphoma, presence of diffuse large B-cell lymphoma, presence of plasmablastic lymphoma."
  }
}